NewEdge Wealth LLC purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 2,432 shares of the semiconductor company’s stock, valued at approximately $1,085,000.
Several other large investors have also made changes to their positions in SNPS. Sankala Group LLC bought a new position in shares of Synopsys in the 4th quarter valued at $25,000. Elevation Wealth Partners LLC boosted its stake in Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after buying an additional 27 shares in the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in Synopsys in the fourth quarter valued at about $28,000. IMG Wealth Management Inc. bought a new position in Synopsys in the second quarter valued at about $28,000. Finally, Atlas Capital Advisors Inc. acquired a new position in Synopsys during the fourth quarter worth about $32,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Analyst Ratings Changes
SNPS has been the topic of a number of research analyst reports. Wells Fargo & Company reduced their price target on shares of Synopsys from $535.00 to $450.00 and set an “equal weight” rating on the stock in a research note on Tuesday, August 11th. Piper Sandler upgraded shares of Synopsys from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $450.00 to $550.00 in a research report on Tuesday, June 23rd. KeyCorp reissued an “overweight” rating on shares of Synopsys in a research note on Wednesday. Citigroup raised their target price on shares of Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Finally, Bank of America boosted their target price on shares of Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Synopsys presently has a consensus rating of “Moderate Buy” and an average target price of $563.59.
Synopsys Stock Performance
Synopsys stock opened at $397.87 on Friday. The business has a 50 day moving average of $419.73 and a 200-day moving average of $440.22. The company has a market capitalization of $76.18 billion, a P/E ratio of 92.10, a P/E/G ratio of 2.34 and a beta of 1.23. Synopsys, Inc. has a 1 year low of $366.00 and a 1 year high of $615.79. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The business had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same period last year, the company earned $3.67 EPS. The firm’s revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities research analysts predict that Synopsys, Inc. will post 10.65 earnings per share for the current year.
Insider Buying and Selling at Synopsys
In related news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by company insiders.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
